Amphotericin BThird Party Manufacturing in India

Amphotericin B is a potent polyene antifungal agent that works by binding to sterols, primarily ergosterol, in the cell membrane of susceptible fungi. This binding alters the permeability of the membrane by creating transmembrane pores or channels. These pores allow the leakage of intracellular potassium, magnesium, and other essential molecules, leading to the collapse of cellular osmotic balance and subsequent death of the fungal cell. Additionally, amphotericin B induces oxidative stress within the fungal cell through the generation of reactive oxygen species, contributing to its fungicidal activity.

Unlike modern azole antifungals which only inhibit fungal growth, Amphotericin B is rapidly fungicidal and active against a very broad spectrum of pathogenic fungi. Because mammalian cell membranes contain cholesterol instead of ergosterol, the drug binds preferentially to fungal membranes. However, its affinity for cholesterol is responsible for its characteristic dose-limiting nephrotoxicity. Formulating amphotericin B into lipid-based complexes, liposomes, or emulsions significantly alters its pharmacokinetics, reducing accumulation in the kidneys and improving the drug's safety profile while maintaining its potent antifungal activity.

Amphotericin B third party manufacturing in India provides specialized, life-saving lipid-based and conventional formulations for severe systemic fungal infections.

Therapeutic Uses

Amphotericin B injection is prescribed for the treatment of:

• Invasive Fungal Infections: First-line therapy for life-threatening systemic fungal infections including invasive aspergillosis, blastomycosis, coccidioidomycosis, and histoplasmosis.
• Cryptococcal Meningitis: A critical treatment in immunocompromised patients, particularly those with HIV/AIDS.
• Visceral Leishmaniasis (Kala-azar): Recommended by health agencies as a highly effective therapy for visceral leishmaniasis, especially in drug-resistant cases.
• Empiric Antifungal Therapy: Used in febrile, neutropenic patients with suspected fungal infections who fail to respond to antibacterial therapy.

Why Choose a Leading Amphotericin B Manufacturer

The manufacturing of lipid-based and liposomal Amphotericin B formulations is highly complex and requires state-of-the-art technology. These specialized formulations require strict aseptic processing, precise lipid chemistry control, and sophisticated particle-size monitoring. Partnering with a WHO-GMP certified manufacturer in India allows distributors to access these premium, complex injectables with assured bioequivalence, stable shelf life, and international compliance. We maintain strict WHO-GMP compliance throughout our production processes.

We offer comprehensive contract manufacturing services for this molecule, and you can view our full range of products in our manufacturing listing. Please contact our team to discuss your specific requirements.

This makes Amphotericin B one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.